Ratings by JPMorgan (Lilia-Celine B Lozada)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2026 | Envista Holdings Corp. | NVST | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/11/2026 | AtriCure Inc. | ATRC | Downgrade | Neutral (Overweight) |
36.92 (35.04) |
-5.09% | Details | |
| 2/6/2026 | Envista Holdings Corp. | NVST | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/16/2025 | AtriCure Inc. | ATRC | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/7/2025 | Treace Medical Concepts Inc | TMCI | Downgrade | Underweight (Neutral) |
6.25 (4.00) |
-36% | Details | |
| 8/8/2025 | Treace Medical Concepts Inc | TMCI | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/30/2025 | AtriCure Inc. | ATRC | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/9/2025 | Treace Medical Concepts Inc | TMCI | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/27/2025 | AtriCure Inc. | ATRC | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/28/2025 | Treace Medical Concepts Inc | TMCI | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/11/2025 | AtriCure Inc. | ATRC | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/17/2024 | Treace Medical Concepts Inc | TMCI | New Coverage | Neutral (N/A) |
7.59 (6.25) |
-17.65% | Details | |
| 12/17/2024 | AtriCure Inc. | ATRC | New Coverage | Overweight (N/A) |
31.54 (36.92) |
17.06% | Details |
